Colorectal Cancer
Quiz
True or False: Doublet therapy for metastatic BRAF variant colorectal cancer is not cost-effective under current pricing.True or False: Doublet therapy for metastatic BRAF variant…
Videos
Kimberly Miller, PhD, MPH, discusses results from a study exploring HRQoL in colorectal cancer survivors who were…
Podcast
Priyanka Kumar, MD, discusses a recent study which analyzed adherence to the NCCN treatment guidelines for anal…
Conference Coverage
Results from a real-world study show tumor mutation burden is unlikely indicative of checkpoint inhibitor response for…
News
While the use of doublet therapy for treating patients with metastatic BRAF variant colorectal cancer is associated…
